Microbot Medical (NASDAQ:MBOT) Stock Price Down 1.2%

Share on StockTwits

Microbot Medical Inc (NASDAQ:MBOT)’s share price was down 1.2% on Friday . The company traded as low as $5.07 and last traded at $5.09. Approximately 266 shares changed hands during mid-day trading, a decline of 99% from the average daily volume of 49,291 shares. The stock had previously closed at $5.15.

The firm has a market capitalization of $21.54 million, a price-to-earnings ratio of -2.07 and a beta of 5.31. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.96 and a quick ratio of 2.96.

A number of institutional investors have recently added to or reduced their stakes in MBOT. Morgan Stanley increased its stake in Microbot Medical by 491.7% in the first quarter. Morgan Stanley now owns 3,568 shares of the biotechnology company’s stock valued at $28,000 after purchasing an additional 2,965 shares during the last quarter. Geode Capital Management LLC acquired a new position in Microbot Medical in the fourth quarter valued at $38,000. BlackRock Inc. increased its stake in Microbot Medical by 3,478.9% in the first quarter. BlackRock Inc. now owns 173,614 shares of the biotechnology company’s stock valued at $1,345,000 after purchasing an additional 168,763 shares during the last quarter. Finally, Renaissance Technologies LLC increased its stake in Microbot Medical by 184.8% in the first quarter. Renaissance Technologies LLC now owns 196,049 shares of the biotechnology company’s stock valued at $1,519,000 after purchasing an additional 127,200 shares during the last quarter. Hedge funds and other institutional investors own 14.00% of the company’s stock.

COPYRIGHT VIOLATION WARNING: This story was first reported by Ticker Report and is the property of of Ticker Report. If you are accessing this story on another website, it was illegally stolen and republished in violation of United States and international copyright & trademark laws. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/4371745/microbot-medical-nasdaqmbot-stock-price-down-1-2.html.

About Microbot Medical (NASDAQ:MBOT)

Microbot Medical Inc, a pre-clinical medical device company, researches, designs, and develops micro-robotics assisted medical technologies targeting the minimally invasive surgery space. The company, through its ViRob and TipCAT micro-robotic technologies, is developing two product candidates, including the Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; and a self-propelling, semi-disposable endoscope, which is used in colonoscopy procedures.

See Also: Key terms to understand channel trading

Receive News & Ratings for Microbot Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbot Medical and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Barry Zwarenstein Sells 7,663 Shares of Five9 Inc  Stock
Barry Zwarenstein Sells 7,663 Shares of Five9 Inc Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc  Stock
Venture Fund Vii L.P. Arch Sells 63,000 Shares of Syros Pharmaceuticals Inc Stock
Insider Selling: Neogen Co.  Director Sells 5,000 Shares of Stock
Insider Selling: Neogen Co. Director Sells 5,000 Shares of Stock
Neogen Co.  Director Sells $314,650.00 in Stock
Neogen Co. Director Sells $314,650.00 in Stock
Insider Selling: Airgain Inc  CEO Sells 22,464 Shares of Stock
Insider Selling: Airgain Inc CEO Sells 22,464 Shares of Stock
Insider Selling: Bottomline Technologies  Insider Sells 9,925 Shares of Stock
Insider Selling: Bottomline Technologies Insider Sells 9,925 Shares of Stock


© 2006-2019 Ticker Report